Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Treatment.com AI Inc. (TREIF)

Compare
0.3136
+0.0136
+(4.53%)
At close: April 9 at 4:00:00 PM EDT
Loading Chart for TREIF
  • Previous Close 0.3000
  • Open 0.2600
  • Bid 0.3000 x --
  • Ask 0.4500 x --
  • Day's Range 0.2600 - 0.3000
  • 52 Week Range 0.0471 - 0.9116
  • Volume 4,770
  • Avg. Volume 15,208
  • Market Cap (intraday) 17.245M
  • Beta (5Y Monthly) -0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Treatment.Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.

www.treatment.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TREIF

View More

Performance Overview: TREIF

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

TREIF
15.13%
S&P/TSX Composite index (^GSPTSE)
3.63%

1-Year Return

TREIF
35.15%
S&P/TSX Composite index (^GSPTSE)
6.11%

3-Year Return

TREIF
89.60%
S&P/TSX Composite index (^GSPTSE)
8.47%

5-Year Return

TREIF
98.06%
S&P/TSX Composite index (^GSPTSE)
67.49%

Compare To: TREIF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TREIF

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    14.96M

  • Enterprise Value

    14.89M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.44k

  • Price/Book (mrq)

    67.76

  • Enterprise Value/Revenue

    1.93k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -221.31%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    38.14k

  • Net Income Avi to Common (ttm)

    -2.01M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3M

  • Total Debt/Equity (mrq)

    46.41%

  • Levered Free Cash Flow (ttm)

    -1.01M

Research Analysis: TREIF

View More

Company Insights: TREIF

Research Reports: TREIF

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.